Morepen Laboratories Dirección
Dirección controles de criterios 3/4
El CEO de Morepen Laboratories es Sushil Suri, nombrado en Oct 2000, tiene una permanencia de 24.08 años. posee directamente un 1.22% de las acciones de la empresa, con un valor de ₹522.17M. La antigüedad media del equipo directivo y de la junta directiva es de 7.9 años y 4.8 años, respectivamente.
Información clave
Sushil Suri
Chief Executive Officer (CEO)
₹39.1m
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 24.1yrs |
| Participación del CEO | 1.2% |
| Permanencia media de la dirección | 7.9yrs |
| Promedio de permanencia en la Junta Directiva | 4.8yrs |
Actualizaciones recientes de la dirección
Recent updates
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump
Aug 20
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)
Aug 09Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified
Jul 05Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | ₹39m | n/a | ₹962m |
| Dec 31 2023 | n/a | n/a | ₹761m |
| Sep 30 2023 | n/a | n/a | ₹531m |
| Jun 30 2023 | n/a | n/a | ₹477m |
| Mar 31 2023 | ₹48m | ₹44m | ₹387m |
| Dec 31 2022 | n/a | n/a | ₹428m |
| Sep 30 2022 | n/a | n/a | ₹553m |
| Jun 30 2022 | n/a | n/a | ₹768m |
| Mar 31 2022 | ₹91m | ₹87m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹54m | ₹51m | ₹971m |
| Dec 31 2020 | n/a | n/a | ₹814m |
| Sep 30 2020 | n/a | n/a | ₹684m |
| Jun 30 2020 | n/a | n/a | ₹453m |
| Mar 31 2020 | ₹17m | ₹16m | ₹336m |
| Dec 31 2019 | n/a | n/a | ₹331m |
| Sep 30 2019 | n/a | n/a | ₹312m |
| Jun 30 2019 | n/a | n/a | ₹340m |
| Mar 31 2019 | ₹12m | ₹11m | ₹288m |
| Dec 31 2018 | n/a | n/a | ₹252m |
| Sep 30 2018 | n/a | n/a | ₹267m |
| Jun 30 2018 | n/a | n/a | ₹308m |
| Mar 31 2018 | ₹6m | ₹4m | ₹296m |
Compensación vs. Mercado: La compensación total de Sushil($USD463.09K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD266.16K).
Compensación vs. Ingresos: La compensación de Sushil ha sido consistente con los resultados de la empresa en el último año.
CEO
Sushil Suri (60 yo)
24.1yrs
Permanencia
₹39,112,000
Compensación
Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 24.1yrs | ₹39.11m | 1.22% ₹ 522.2m | |
| Whole-Time Director | 9.8yrs | ₹21.80m | 1.01% ₹ 429.8m | |
| Chief Financial Officer | 10.3yrs | ₹9.80m | sin datos | |
| General Manager of Process Engineering & Technology Transfer | no data | sin datos | sin datos | |
| Manager of Administration | no data | sin datos | 0.58% ₹ 248.7m | |
| Company Secretary & Compliance Officer | 6yrs | ₹1.84m | sin datos | |
| Functional Head of Talent Acquisition & HRBP | less than a year | sin datos | sin datos | |
| Chief Operating Officer of API | less than a year | sin datos | sin datos | |
| Head of Medipath Division | no data | sin datos | 0.42% ₹ 177.8m | |
| Head of International Business Development | no data | sin datos | sin datos | |
| Chief Executive Officer of Consumer Division | no data | sin datos | 0.56% ₹ 237.8m | |
| Chief of R&D | no data | sin datos | sin datos |
7.9yrs
Permanencia media
47.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MOREPENLAB es experimentado (7.9 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & MD | 32.8yrs | ₹39.11m | 1.22% ₹ 522.2m | |
| Whole-Time Director | 5.3yrs | ₹21.80m | 1.01% ₹ 429.8m | |
| Independent Director | less than a year | sin datos | sin datos | |
| Independent Director | 5.3yrs | ₹520.00k | sin datos | |
| Independent Director | 4.4yrs | ₹300.00k | sin datos | |
| Independent Director | less than a year | sin datos | sin datos |
4.8yrs
Permanencia media
56yo
Promedio de edad
Junta con experiencia: La junta directiva de MOREPENLAB se considera experimentada (4.8 años de antigüedad promedio).